April 2023 - Page 8 of 16

MondayApr 17, 2023 11:59 am

QualityStocksNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Plans to Release Q4, FY 2022 Financial Report Later Today

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, announced that it will release financial information later today. The financial report will for the fourth quarter and full year 2022. In addition, the company noted that it has scheduled an earnings call, which will begin at 4:30 p.m. ET today. During the call, company management will discuss the earnings report. Those interested in attending the call can dial 1-877-407-4018 in the United States or 1-201-689-8471 internationally. The call will also be available as a webcast. In addition, a…

MondayApr 17, 2023 11:15 am

Data443 Risk Mitigation Inc.’s (ATDS) Award-Winning Ransomware Defense Shines as Cybercrime Persists

As the world becomes increasingly digital, cyber threats abound with the cost of cybercrime predicted to hit $10.5 trillion by 2025 The global cyber security solutions market is projected to grow from $155.83 billion in 2022 to $376.32 billion by 2029, exhibiting a CAGR of 13.4% during the forecast period Data443 Risk Mitigation offers both comprehensive and a la carte solutions for companies to mitigate cybersecurity risks PC Magazine named Data443’s Ransomware Recovery Manager as “Best for Inexpensive Protection” and “Best for Kiosks” in its “The Best Ransomware Protection for 2023” list Our increasing global dependence on digital infrastructure is…

MondayApr 17, 2023 11:07 am

QualityStocksNewsBreaks – Battery Mineral Resources Corp. (TSX.V: BMR) (OTCQB: BTRMF) to Attend CESCO; Announces Interest Settlement Agreements

Battery Mineral Resources (TSX.V: BMR) (OTCQB: BTRMF) senior executives plan to attend the Centro de Estudios de Cobre y la Mineria (“CESCO”) event in Santiago, Chile; the weeklong event is scheduled to kick off April 17, 2023. Those company officials will also attend the World Copper Conference, held in conjunction with CESCO. With an estimated 2,000 attendees, including some of the industry’s best-known miners and smelters, CESCO has built a reputation for providing some of the most important commercial and networking opportunities in the mining industry. In addition, BMR announced that it has entered into interest settlement agreements with certain holders…

MondayApr 17, 2023 10:30 am

Cartier Silver Corp. (CSE: CFE) Follows in Eloro Resources Ltd.’s (TSX: ELO) (OTCQX: ELRRF) Footsteps Within Bolivia’s Potosi Region

Cartier Iron opted to change its name to Cartier Silver in October 2022, part of a wider pivot within its business plan The revamped company, which is both a sister company and minority shareholder in Eloro Resources (TSX: ELO), recently optioned 100% of the zinc-silver Los Chorrillos Project, within Bolivia’s Cerro Rico region The company, which boasts the same, experienced management team as Eloro Resources’, recently completed their initial capital raise of $3 million Proceeds from the capital raise will be used to finance initial exploration at the Los Chorillos site In October 2022, when Cartier Iron made a dramatic…

MondayApr 17, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyes the Licensed Use of its DehydraTECH(TM) Technology to Complement its Royalty Earnings and Realize Revenue in Advance of Royalties

Chris Bunka, Lexaria’s CEO, has reiterated the company’s commitment to creating value for its shareholders with the licensed use of its patented DehydraTECH(TM) technology Mr. Bunka has noted that Lexaria is already in discussions with interested parties in Europe and North America, a move that presents a critical fiscal opportunity for the company He has emphasized how profitable new licensing agreements could be for the company, presenting additional avenues for Lexaria to generate revenue and create value for its shareholders As the company continues to make a transition toward a more commercial focus in 2023, Bunka notes that licensing will…

MondayApr 17, 2023 9:00 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Set to Scale its Maximum Production Rate to 7,500 TPA Following the Selection of LSMC REE Separation and Oxide Production Facility

Ucore just announced the selection of an 80,800 square-foot brownfield facility located in England Airpark in Alexandria, Louisiana, that will serve as the company’s LSMC REE separation and oxide production facility The company is confident that the establishment will expand its maximum production rate from the current 5,000 TPA to 7,500 TPA in TREO throughout by 2027 The facility is expected to create 298 indirect jobs, for a total of 398 new jobs in Central Louisiana. It is also set to bring the total potential value of state grants, tax incentives, 1payroll rebates, and other benefits to US$15 million Ucore…

FridayApr 14, 2023 3:49 pm

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) Helping Clients Address Cybersecurity at the Enterprise Level

SideChannel (OTCQB: SDCH) is a cybersecurity services and technology provider whose key service is providing virtual chief information security officers (“vCISOs”) on contract to small and medium-sized businesses (“SMBs”) without the budget capacity to hire their own full-time CISOs. “SideChannel’s cybersecurity experts are presented to clients as guidance providers who can work in the boardroom alongside the companies’ leading officers. ‘The cybersecurity profession is now akin to legal, accounting and insurance,’ SideChannel CEO Brian Haugli said during a live company webcast recently. ‘When we look inside organizations at the enterprise level, we see the CISO right there with HR (Human…

FridayApr 14, 2023 12:51 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Positive Results in First Diabetes Study

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is increasing the bioavailability of and improving the way that active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery with its patented DehydraTECH(TM). “Most recently, a company announcement indicates that a just-completed DIAB-A22-1 diabetes study has produced at least three positive outcomes, including weight loss in obese diabetic-conditioned animals and improved triglyceride and cholesterol levels. The animals tested in the study showed these dramatic changes in as few as three days when dosed with DehydraTECH-processed cannabidiol (‘CBD’), aligned with other study work pointing to…

FridayApr 14, 2023 12:38 pm

QualityStocksNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Announces Q4 and Year-End 2022 Results

D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, and the only commercial provider building both annealing and gate-model quantum computers, today announced financial results for its fourth quarter and fiscal year ended Dec. 31, 2022. “We believe our fourth quarter and 2022 year-end results reflect a clear signal: companies are rapidly embracing today’s quantum technology solutions to drive competitive advantage, now. In this complex economic environment, business leaders are actively looking for ways to improve operational efficiencies, reduce costs, fuel innovation, and increase revenue. We believe that near-term quantum and quantum-hybrid applications are critical for navigating…

FridayApr 14, 2023 11:29 am

QualityStocksNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Leveraging Innovative NanoAb Pipeline to Disrupt High-Value Market Opportunities

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. “In many compelling ways, BiondVax punches well above its weight compared to biopharma companies of similar market cap: BiondVax gained extensive drug development expertise [through previous clinical trials evaluating the M-001 universal influenza vaccine candidate], which is expected to be invaluable in the development and commercialization of the NanoAb pipeline. The company plans to undertake the first-in-human phase 1/2a clinical trial evaluating its inhaled anti-COVID-19 NanoAb therapy later this year. This rapid development path hinges…

Site Search

Company Search

Month: April 2023